Bioject Medical Technologies (BJCT) Shares Surge On Expanded Agreement
Bioject Medical Technologies (NASDAQ:BJCT - News) shares jumped 22% after the company said it has expanded its agreement with an unnamed European biotechnology company. Portland, Ore.-based Bioject said it entered into the next phase of development for a new needle-free drug delivery system with the company for an undisclosed indication. Although financial terms of the deal were not disclosed, Bioject said the expanded agreement includes the payment of an upfront fee, as well as additional milestone payments.
posted by Stock Administrator @ 10:27 PM
0 Comments:
Post a Comment
<< Home